Navigation Links
Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues
Date:9/24/2009

0% improvement of sales in the quarter of Neogen's veterinary vitamin injectables that are used primarily for prevention and treatment of vitamin deficiencies in cattle and sheep.

Sales of veterinary products through over-the-counter distributor channels were led by strong increases in sales of products to treat wounds, and leg and foot conditions. The company's Ideal Instruments brand, including disposable needles and syringes, also had a solid quarter with sales growth of 11% compared to the previous year's first quarter.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases, and sanitation concerns, and dehydrated culture media. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

    NEOGEN CORPORATION SUMMARIZED UNAUDITED CONSOLIDATED OPERATING DATA
    (In thousands, except for percentages and per share amounts)

                                             Quarter
                                         Ended Aug. 31
                                        2009      2008
                                        ----      ----
     Revenue
        Food Safety                  $17,476   $15,549
        Animal Safety                 14,871    13,256
                                      ------    ------
     Total revenue                    32,347    28,805
     Cost of sales                    15,077    14,001
                                      ------    ------
     Gross margin                     17,270    14,804
     Other expenses
        Sales & marketing              5,972     5,619
        Administrative                 2,890     2,580

'/>"/>
SOURCE  Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 

Related biology technology :

1. Neogen Acquires Kane Enterprises
2. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
3. Neogen Acquires Assets of Rivard Instruments
4. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
5. Neogen Launches Quickest Test Available for Tetracyclines in Milk
6. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
7. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
8. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
9. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
10. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
11. Neogen Forms Mexican Subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Researchers have discovered a new explanation for differences in the ... of a certain gene, the more serious the handicap. The ... suspected that it is the amount of copies of the ... in the American Journal of Human Genetics , and ... Froyen connected to VIB, a life sciences research institute in ...
(Date:12/11/2009)... Corporation announced today the enrollment and dosing at the ... the first patient in the ACE ( AC ... 2 pivotal trial in patients with relapsed or refractory ... orally available, potent and highly selective small molecule that ... inhibitor. The ACE study is designed to be ...
(Date:12/11/2009)... Bio Innovations (MBI) today announces 2 new additions ... joined MBI as Senior Vice President of Commercial ... aspects of the company, including sales, marketing, and ... joined MBI as Vice President of Process Development, ... its broad pipeline of products to commercial manufacturing ...
(Date:12/11/2009)... CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... today announced the appointment of Dr. Alan Warrander ... Licensing and Business Development. ,, "Dr. Warrander will ... licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson, ... agreement on the design of a Phase 3 ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Food and Other Packaging Uses, MELBOURNE, Australia, ... DD ) and Plantic Technologies Limited, an Australian ... in the development and sale of renewably sourced ... collaborative development of new, renewably sourced,resins and sheet ...
... Trials Complete for Limited-English Interpretation, TUCSON, ... important for serving limited-English speaking patients in,hospitals ... enhanced with the,development of the industry,s first ... was CyraCom,s invention of its patented,dual-handset phone ...
... Agendia BV, a world leader in,the rapidly evolving field ... US-based Personalized Medicine Coalition (PMC). "The PMC is ... policy on,personalized medicine. We are very pleased to be ... treatment of patients in the future. After we,got both ...
Other Biology Technology:DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration 2DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration 3Industry-First Telephone for Health Care Developed by CyraCom 2Agendia Joins the Personalized Medicine Coalition (PMC) 2
(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...
(Date:12/15/2009)... ., Despite the fact that physical space follows ... to how space is encoded in their language. Some, ... ,left, right, front, back, to talk about spatial relations, ... at all times for all scales: "The spoon is ... by your Northern leg". Whether not only spatial language ...
(Date:12/15/2009)... forward to ultra-low powered or self powered electronic ... This is made possible with power management and ... for power optimisation and higher energy efficiency in ... is the key enabling capability for power management ... advanced analog and mixed signal design capabilities, Singapore,s ...
Breaking Biology News(10 mins):More than a jump to the left 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Hanes 28R 29 and Susan G Komen for the Cure 28R 29 Inspire Creativity for a Cause 54718 1Hanes 28R 29 and Susan G Komen for the Cure 28R 29 Inspire Creativity for a Cause 54718 2Hanes 28R 29 and Susan G Komen for the Cure 28R 29 Inspire Creativity for a Cause 54718 3Hanes 28R 29 and Susan G Komen for the Cure 28R 29 Inspire Creativity for a Cause 54718 4Aethlon Medical to Present at Todays Southern California Investor Conference 54714 1Aethlon Medical to Present at Todays Southern California Investor Conference 54714 2Taiwanese Hospital Deploys VoSKY Exchange to Connect Medical Staff to Nursing Trolley via Skype 54711 1Taiwanese Hospital Deploys VoSKY Exchange to Connect Medical Staff to Nursing Trolley via Skype 54711 2
... materials, invented by researchers at the University of Illinois, ... The new materials rely upon embedded, three-dimensional microvascular networks ... manner that a cut in the skin triggers blood ... materials will trigger the flow of healing agent to ...
... Center researchers have uncovered a new mechanism of action ... development of novel regimens in which it is combined ... cancers and solid tumors. , In the new ... for translational research and co-leader of the cancer center’s ...
... it comes to dressing their children, at least among ... States. Researchers at the University of California, Santa Cruz, ... induce different color patterns in their offspring in response ... will wear for the rest of their lives. The ...
Other Biology News:Now, self-healing materials can mimic human skin, healing again and again 2Researchers shed light on mechanism of action used by anti-cancer drug 2Study shows lizard moms dress their children for success 2Study shows lizard moms dress their children for success 3Study shows lizard moms dress their children for success 4
...
...
Practical tool for easy, effective sealing of 0.2ml PCR tubes and plates using cap strips....
Kit for testing the ability of a compound to simulate lipolysis in cultured human adipocytes. Kit contains controls, buffers and reagents for detecting glycerol and non-esterified free fatty acids. A...
Biology Products: